US2023301558A1PendingUtilityA1

Low oxygen in vivo analyte sensor

Assignee: DEXCOM INCPriority: Jan 17, 2006Filed: Feb 28, 2023Published: Sep 28, 2023
Est. expiryJan 17, 2026(expired)· nominal 20-yr term from priority
A61B 5/14532A61B 5/14865A61B 5/0002A61B 5/0031A61B 5/145A61B 5/14503A61B 5/1495A61B 5/150022A61B 5/6846
80
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous and subcutaneous measurement of glucose in a host.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . An analyte sensor system comprising:
 a transcutaneous analyte sensor body comprising an electrode configured to measure a glucose level in a host;   a membrane disposed over the electrode, the membrane comprising:
 a first layer configured to limit transport of glucose to the electrode; and 
 a second layer comprising an enzyme to catalyze a reaction of glucose and oxygen as a co-reactant; and 
   a sensor electronics unit operably connected to the electrode and configured to measure a current produced by the electrode, wherein the sensor electronics unit is configured to measure glucose concentration with substantial linearity at glucose concentrations of up to about 400 mg/dL at an oxygen concentration of 0.6 mg/L.

Join the waitlist — get patent alerts

Track US2023301558A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.